Pediatric antimicrobial therapy. VI.
D000890:Anti-Infective Agents / Q000627:therapeutic use*; D001196:Ascariasis / Q000188:drug therapy; D004169:Diphyllobothriasis / Q000188:drug therapy; D005873:Giardiasis / Q000188:drug therapy; D006801:Humans; D008795:Metronidazole / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D009534:Niclosamide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D010123:Oxyuriasis / Q000188:drug therapy; D010372:Pediatrics; D010879:Piperazines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D011774:Pyrvinium Compounds / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D013622:Taeniasis / Q000188:drug therapy
D000890:Anti-Infective Agents; D010879:Piperazines; D011774:Pyrvinium Compounds; D008795:Metronidazole; D009534:Niclosamide